Explore All Access
Check if your research matches the topics covered in Experimental Hematology and Oncology?
- Degree of match
- Common matching concepts
- Additional journal recommendations
Experimental Hematology and Oncology : Impact Factor & More
eISSN: 2162-3619pISSN: 2162-3619
Open AccessShare this on:
Check your submission readiness
Find out how your manuscript stacks up against 24 technical compliance and 6 language quality checks.
Experimental Hematology and Oncology Key Metrics
CiteScore 
8.1
Eigenfactor
0.001 - 0.005
Impact Factor
5 - 10
SJR
Q2Oncology
SNIP
1.39
Time to Publish
View Chart Mo
Topics Covered on Experimental Hematology and Oncology
Hepatocellular carcinoma
Notch signaling pathway
Bone marrow
Protein kinase A
Maximum tolerated dose
Overall survival
Photopheresis
Chimeric antigen receptor
Peripheral T-cell lymphoma
Post-transcriptional regulation
Arsenic
Diffuse large B-cell lymphoma
Clinical trial
Cell therapy
Fusion gene
Polycythemia vera
Immunotherapy
Phosphoglycerate dehydrogenase
Burden of disease
Untranslated region
Experimental Hematology and Oncology Journal Specifications
| Overview | |
| Publisher | BMC |
| Language | English |
| Frequency | Continuous publication |
| Article Processing Charges | EUR 2590 | USD 2990 | GBP 2290 |
| Publication Time | 6 |
| Editorial Review Process | Anonymous peer review |
| General Details | |
| Language | English |
| Frequency | Continuous publication |
| Publication Start Year | 2012 |
| Publisher URL | Visit website |
| Website URL | Visit website |
| Publication Details | |
| Editorial Review Detail | |
| Information for authors | |
| Author instructions | Visit website |
| Copyright Details | Visit website |
| Deposit Policy | Sherpa/Romeo |
| License type | CC BY, CC0 |
| OA statement | Visit website |
View less
One subscription packed with expert publication services and AI tools to get you published
Brought to you by 
Journal Selection Service
Benefit from our experts' recommendations of 3-5 best-suited journals, accompanied by a detailed Journal Selection report explaining the choices. Make informed decisions.
Journal Submission Service
Streamline your submission process with meticulous manuscript formatting to meet journal guidelines, crafting a tailored cover letter for the editor, and hassle-free account creation and submission
Bundle of AI tools for your research needs
Journal Finder, Paperpal, R Discovery, MindTheGraph and more
Time to Publish
% of papers by time taken from submission to publication
0 to 3 months49%
4 to 6 months47%
7 to 9 months4%
Above 9 months0%
Did you find this useful?
Planning to publish in Experimental Hematology and Oncology ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in Experimental Hematology and Oncology
A Fab of trastuzumab to treat HER2 overexpressing breast cancer brain metastases.
- 15 Apr 2024
- Experimental hematology & oncology
Targeting natural killer cells: from basic biology to clinical application in hematologic malignancies.
- 23 Feb 2024
- Experimental hematology & oncology
Blockade of the lncRNA-DOT1L-LAMP5 axis enhances autophagy and promotes degradation of MLL fusion proteins.
- 19 Feb 2024
- Experimental hematology & oncology
Correction: Breast cancer heterogeneity and its implication in personalized precision therapy.
- 23 Jan 2024
- Experimental hematology & oncology
ZMIZ2 facilitates hepatocellular carcinoma progression via LEF1 mediated activation of Wnt/β-catenin pathway.
- 22 Jan 2024
- Experimental hematology & oncology
Crosstalk between colorectal CSCs and immune cells in tumorigenesis, and strategies for targeting colorectal CSCs.
- 22 Jan 2024
- Experimental hematology & oncology
A Fab of trastuzumab to treat HER2 overexpressing breast cancer brain metastases.
- 15 Apr 2024
- Experimental hematology & oncology
Targeting natural killer cells: from basic biology to clinical application in hematologic malignancies.
- 23 Feb 2024
- Experimental hematology & oncology
Blockade of the lncRNA-DOT1L-LAMP5 axis enhances autophagy and promotes degradation of MLL fusion proteins.
- 19 Feb 2024
- Experimental hematology & oncology
Correction: Breast cancer heterogeneity and its implication in personalized precision therapy.
- 23 Jan 2024
- Experimental hematology & oncology
ZMIZ2 facilitates hepatocellular carcinoma progression via LEF1 mediated activation of Wnt/β-catenin pathway.
- 22 Jan 2024
- Experimental hematology & oncology
Crosstalk between colorectal CSCs and immune cells in tumorigenesis, and strategies for targeting colorectal CSCs.
- 22 Jan 2024
- Experimental hematology & oncology
Compare Similar Journals with Experimental Hematology and Oncology
Select Journals to Compare with Experimental Hematology and Oncology
Total journals - 10
You can select up to 3 Journals at a time
Blood
Publisher: AMER SOC HEMATOLOGY
Journal of Clinical Oncology
Publisher: LIPPINCOTT WILLIAMS & WILKINS
Frontiers in Oncology
Publisher: FRONTIERS MEDIA SA
Cancer Research
Publisher: AMER ASSOC CANCER RESEARCH
Cancers
Publisher: MDPI
Frontiers in Immunology
Publisher: FRONTIERS MEDIA SA
International Journal of Molecular Sciences
Publisher: MDPI
Oncotarget
Publisher: Impact Journals
Scientific Reports
Publisher: NATURE PORTFOLIO
PLoS ONE
Publisher: PUBLIC LIBRARY SCIENCE
0 Journals Selected to compare with
Experimental Hematology and Oncology
Compare journals across 7 parameters SJR Ranking, Topics covered, Indexing Database, Publication Review Time, Publication Type, Article Processing Charges & Recently Published papers
SJR Ranking, Topics covered, Indexing Database, Publication Review Time, Publication Type, Article Processing Charges & Recently Published papers
Get detailed Journal comparison report on your email by signing up
FAQs on Experimental Hematology and Oncology
How long has Experimental Hematology and Oncology been actively publishing? 
Experimental Hematology and Oncology has been in operation since 2012 till date.
What is the publishing frequency of Experimental Hematology and Oncology?
Experimental Hematology and Oncology published with a Continuous publication frequency.
How many articles did Experimental Hematology and Oncology publish last year?
In 2023, Experimental Hematology and Oncology publsihed 1 articles.
What is the eISSN & pISSN for Experimental Hematology and Oncology?
For Experimental Hematology and Oncology, eISSN is 2162-3619 and pISSN is 2162-3619.
What is Citescore for Experimental Hematology and Oncology?
Citescore for Experimental Hematology and Oncology is 8.1.
What is SNIP score for Experimental Hematology and Oncology?
SNIP score for Experimental Hematology and Oncology is 1.39.
What is the SJR for Experimental Hematology and Oncology?
SJR for Experimental Hematology and Oncology is Q2.
Who is the publisher of Experimental Hematology and Oncology?
BMC is the publisher of Experimental Hematology and Oncology.
